首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

2075107

個人化基因組學市場：按檢測類型、技術、應用、最終用戶和地區分類

Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，個人化基因組學市場規模預計為147.3億美元，預計2033年將達到452.9億美元。預計2026年至2033年，該市場將以17.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	147.3億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	17.40%	2033年市場規模預測：	452.9億美元

個人化基因組學是一個快速發展的領域，它結合了遺傳學、基因組學和個人化醫療，為了解個人的基因組成提供了寶貴的見解。

市場動態：

全球個人化基因組學市場受多種因素驅動。首先，慢性病盛行率的不斷上升以及對個人化治療方案日益成長的需求，催生了對基因檢測服務的需求。個人化基因組學有助於識別特定疾病的高風險族群，從而實現早期療育和標靶治療。例如，根據2020年9月發表在《預防慢性病》（Preventing Chronic Disease）雜誌上的報導，2018年，51.8%的非機構居住成年人被診斷患有至少一種選定的10種慢性病。更具體地說，24.6%的成年人患有一種慢性病，27.2%的成年人患有兩種或兩種以上的慢性病。

此外，次世代定序和生物資訊學等技術的進步使得基因檢測更加普及和經濟實惠。這擴大了提供個人化基因組學服務的公司的基本客群。

然而，該市場也面臨一些限制。基因資訊高度敏感，若保護不當可能被濫用，引發人們對隱私和資料安全的擔憂。監管方面的挑戰以及對基因數據使用和解讀的明確指導方針的需求，也對市場成長構成障礙。

儘管面臨這些挑戰，個人化基因體學市場仍蘊藏著巨大的機會。將人工智慧和機器學習演算法融入基因分析可以提高個人化基因組學服務的準確性和效率。此外，面向消費者的基因檢測的普及以及醫療機構對基因檢測的日益廣泛應用，也為該市場的企業創造了良好的成長前景。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球個人化基因組學市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球個人化基因組學市場報告的目標受群眾外包括行業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球個人化基因組學市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 以色列
- 南非
- 北非
- 中非
- 其他中東國家

第9章競爭情勢

23andMe
Mapmygenome
Invitea
Genetic Technology Limited
Lonza
Interleukin Genetics, Inc
GNA Genotek
Helix
MyHeritage
Pathway Genomics
Veritas Genetics
Xcode
Color Genomics
Myriad Genetics
Quest Diagnostics
Bio-Rad Laboratories, Inc.
Illumina
Thermo Fisher Scientific
Qiagen
Genomic Health
Nebula Genomics

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI6210

Personalized Genomics Market is estimated to be valued at USD 14.73 Bn in 2026 and is expected to reach USD 45.29 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 14.73 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	17.40%	2033 Value Projection:	USD 45.29 Bn

Personalized genomics is a rapidly growing field that combines genetics, genomics, and personalized medicine to provide individuals with valuable insights into their genetic makeup.

Market Dynamics:

The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.

Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.

However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.

Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market

Personalized Genomics Market Detailed Segmentation:

By Test Type (Revenue, USD Bn, 2021 - 2033)
Oncology Testing
Infectious Disease Testing
Neurological Testing
Cardiovascular Testing
Others
By Technology (Revenue, USD Bn, 2021 - 2033)
PCR-based Tests
Microarray-based Tests
Sequencing-based Tests
Others
By Application (Revenue, USD Bn, 2021 - 2033)
Diagnostics
Precision Medicine
Wellness
Reproductive Health
Sports Nutrition & Health
Lifestyle
Others
By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals & Clinics
Research Centers
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players
23andMe
Mapmygenome
Invitea
Genetic Technology Limited
Lonza
Interleukin Genetics, Inc
GNA Genotek
Helix
MyHeritage
Pathway Genomics
Veritas Genetics
Xcode
Color Genomics
Myriad Genetics
Quest Diagnostics
Bio-Rad Laboratories, Inc.
Illumina
Thermo Fisher Scientific
Qiagen
Genomic Health
Nebula Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Genomics, By Test Type
- Market Personalized Genomics, By Technology
- Market Personalized Genomics, By Application
- Market Personalized Genomics, By End User
- Market Personalized Genomics, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing demand for personalized medicine and increase in R&D investments
- High costs and complex data interpretation
- Leveraging Big Data and Artificial Intelligence
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Personalized Genomics Market , By Test Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oncology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Neurological Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Cardiovascular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Personalized Genomics Market , By Technology, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
PCR-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Microarray-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Sequencing-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

6. Global Personalized Genomics Market , By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Wellness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Sports Nutrition & Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Lifestyle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

7. Global Personalized Genomics Market , By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

8. Global Personalized Genomics Market , By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

9. Competitive Landscape

23andMe
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mapmygenome
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitea
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genetic Technology Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Interleukin Genetics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GNA Genotek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Helix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MyHeritage
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pathway Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Veritas Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Xcode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Color Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Qiagen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genomic Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nebula Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views